Teriparatide Injection
Product Images NDC 0548-2311

Product Visual Gallery

This gallery contains 21 technical images submitted to the FDA as part of the official labeling for Teriparatide (NDC 0548-2311). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Amphastar Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton (Teriparatidecarton)

Teriparatide Injection 250 mcg/mL prefilled pen carton label from Amphastar Pharmaceuticals, Inc. The label states each pen delivers 28 subcutaneous doses of 20 mcg per dose. Instructions highlight the importance of reading the user manual before injection, storage at 2° to 8°C, and that the product is for single-patient use only. The label also includes ingredients and contact information.*

FDA Label Image

Deliverydevice (Teriparatidedeliverydeviceparts)

Illustration showing parts of the Teriparatide delivery device, including the yellow shaft, black injection button, red stripe, blue body, medicine cartridge, blue cap, paper tab, needle, small needle protector, and large needle cover. A note indicates needles are not included and recommends Becton, Dickinson and Company pen needles for use with the device.*

FDA Label Image

Figure1 (Teriparatidefigure1)

A line graph comparing the percent of patients with nonvertebral osteoporotic fractures over 20 months since randomization between Teriparatide injection and placebo groups. The graph shows two lines: a dotted line for Teriparatide injection and a solid line for placebo, depicting the fracture incidence over time.*

FDA Label Image

Injectorpen (Teriparatideinjectorpen)

Teriparatide 250 micrograms/mL injection in a cartridge form. The cartridge is partly blue and white with a black stopper on one end, designed for subcutaneous administration. The labeler is Amphastar Pharmaceuticals, Inc.*

FDA Label Image

Step1 (Teriparatidestep1)

An instructional illustration showing two hands handling a pen injection device, likely demonstrating how to prepare or operate the Teriparatide 250 mcg/mL subcutaneous injection pen.*

FDA Label Image

Step2a (Teriparatidestep2a)

An instructional illustration showing hands removing a purple cap from the top of an injection pen or vial. This image likely demonstrates part of the preparation process for a Teriparatide subcutaneous injection.*

FDA Label Image

Step2b (Teriparatidestep2b)

An instructional illustration showing hands preparing a prefilled syringe injection. The image demonstrates the removal of the cap from the needle prior to subcutaneous administration, indicated by an arrow pointing to the right. This is a preparatory step for administering Teriparatide injection.*

FDA Label Image

Step2c (Teriparatidestep2c)

An instructional diagram illustrating how to remove a cap from a syringe pen. The image shows two hands: one holding the pen and the other turning the cap counterclockwise to unscrew it.*

FDA Label Image

Step2d (Teriparatidestep2d)

An instructional illustration showing how to remove or handle the large needle cover from a syringe. A hand is depicted gripping the needle cover, highlighted by a blue circle around the fingers and the needle cover, connected to the syringe barrel on the left.*

FDA Label Image

Step3a (Teriparatidestep3a)

An instructional illustration showing two hands, where one hand holds an injection pen and the other hand pulls a protective yellow cap with a red band from the pen, indicated by a black downward arrow. This image likely demonstrates removing the cap from a Teriparatide injection pen before administration.*

FDA Label Image

Step3b (Teriparatidestep3b)

An instructional illustration showing a close-up of hands holding a Teriparatide injection pen. A red stripe on the pen is highlighted within a blue circle, indicating a specific feature or step in the injection process.*

FDA Label Image

Step3c (Teriparatidestep3c)

An instructional illustration showing a hand holding a small needle protector being removed from a syringe needle. The image highlights the action of pulling off the small needle protector from the syringe needle tip.*

FDA Label Image

Step4a (Teriparatidestep4a)

An instructional illustration showing a person administering a subcutaneous injection with a syringe. The image depicts the injection being given into the abdominal area, demonstrating proper technique for self-injection.*

FDA Label Image

Step4b (Teriparatidestep4b)

An instructional illustration showing hands holding a syringe and preparing to inject Teriparatide injection. One hand holds the syringe plunger with an arrow indicating to push it, while the other hand supports the injection site on the skin. A numbered sequence from 1 to 5 is depicted, likely representing steps or counts for injection procedure.*

FDA Label Image

Step5a (Teriparatidestep5a)

An illustration showing a hand holding a small vial with a black cap, surrounded by a blue circle, likely demonstrating how to hold the vial for injection preparation.*

FDA Label Image

Step5b (Teriparatidestep5b)

An instructional illustration showing a hand holding an injection vial with a red prohibition symbol over it, indicating not to hold the vial in that manner. This diagram is related to the proper handling or administration of Teriparatide injection.*

FDA Label Image

Step6a (Teriparatidestep6a)

An instructional diagram illustrating the removal of a large needle cover from a Teriparatide injection pen. The image shows a hand holding the pen with an arrow indicating the direction to pull the needle cover off, highlighting preparation for subcutaneous injection.*

FDA Label Image

Step6b (Teriparatidestep6b)

An instructional diagram showing hands preparing a prefilled injection syringe, illustrating the step of twisting the cap to remove it before administering the Teriparatide 250 mcg/mL subcutaneous injection.*

FDA Label Image

Step6c (Teriparatidestep6c)

An instructional diagram showing a hand holding an injection pen and another hand removing the cap by pulling it off, indicated by a rightward arrow. The illustration appears to demonstrate the first step in preparing a subcutaneous injection.*

FDA Label Image

Step6d (Teriparatidestep6d)

An instructional illustration showing the removal of a blue protective cap from a Teriparatide injection pen. One hand holds the pen steady while the other hand pulls the cap off in the direction indicated by an arrow.*

FDA Label Image

Structure (Teriparatidestructure)

Chemical structure diagram of Teriparatide showing its amino acid sequence from Serine (Ser) at position 1 to Phenylalanine (Phe) at position 34, with labeled positions indicating the peptide chain.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.